Zaltrap IV infusion 100mg, manufactured by Sanofi, contains Aflibercept beta (genetical recombination), a recombinant fusion protein. Marketed as Zaltrap, it is used in combination with chemotherapy for metastatic colorectal cancer. This 100mg 4mL bottle has a YJ code of 4291436A1023.
Zaltrap IV infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).